Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Predictors of Lung Cancer Behavior

NCT00898313 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00898313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Predictors of Lung Cancer Behavior
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
December 31, 2003
Completion date
January 31, 2027
Enrollment
4,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer